Literature DB >> 28993120

Coronary lumen volume to myocardial mass ratio in primary microvascular angina.

Rominder Grover1, Jonathon A Leipsic2, John Mooney1, Shaw-Hua Kueh1, Mickael Ohana1, Bjarne L Nørgaard3, Ashkan Eftekhari3, Jeroen J Bax4, Darra T Murphy1, Cameron J Hague1, Michael A Seidman5, Philipp Blanke1, Tara Sedlak6, Stephanie L Sellers7.   

Abstract

BACKGROUND: Microvascular angina (MVA) is an incompletely understood clinical entity. Computational analysis of coronary Computed Tomography Angiography (CTA) has shown an association between low coronary lumen volume to myocardial mass (V/M) ratio and lower Fractional Flow Reserve values, independent of plaque measures. We hypothesized that low V/M ratio may be present in patients with MVA.
METHODS: A retrospective case-control analysis was performed using patients fulfilling guideline criteria for MVA with controls matched for age, gender, coronary risk factors and atherosclerotic plaque burden. V/M was extracted off site (Heartflow Inc; Redwood City, CA) employing allometric scaling laws that allow the definition of the coronary circulation beyond the epicardium. FFRCT values were calculated in the major epicardial coronary arteries for each group.
RESULTS: A total of 30 patients with MVA and 32 matched controls were included in the study. Mean total coronary lumen volume (2302 mm3 ± 109 vs 2978 mm3 ± 134, p < 0.001) and mean myocardial mass (90.4 g ± 13.7 vs 100.4 g ± 20.1, p = 0.029) were lower in MVA patients compared to controls. Mean V/M ratio was significantly lower in MVA compared to controls (25.6 mm3/g ± 5.9 vs 30.0 mm3/g ± 6.5, p = 0.007; c-statistic 0.69). V/M ratio did not differ significantly between subclasses of angina severity (p = 0.747). No difference in mean nadir FFRCT values was found between MVA and control groups in the LAD (0.86 ± 0.07 vs 0.83 ± 0.07, p = 0.154), LCX (0.90 ± 0.05 vs 0.90 ± 0.06, p = 0.240) and RCA (0.90 ± 0.04 vs 0.90 ± 0.03, p = 0.773) vessels.
CONCLUSION: Patients with microvascular angina demonstrate a significantly lower coronary CTA-derived coronary volume/myocardial mass ratio than asymptomatic controls.
Copyright © 2017 Society of Cardiovascular Computed Tomography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; CTCA; FFR(CT); Microvascular angina

Mesh:

Year:  2017        PMID: 28993120     DOI: 10.1016/j.jcct.2017.09.015

Source DB:  PubMed          Journal:  J Cardiovasc Comput Tomogr        ISSN: 1876-861X


  6 in total

1.  Impact of sublingual nitroglycerin dosage on FFRCT assessment and coronary luminal volume-to-myocardial mass ratio.

Authors:  Kenneth R Holmes; Tim A Fonte; Jonathan Weir-McCall; Malcolm Anastasius; Philipp Blanke; Geoffrey W Payne; Jen Ellis; Darra T Murphy; Charles Taylor; Jonathon A Leipsic; Stephanie L Sellers
Journal:  Eur Radiol       Date:  2019-06-21       Impact factor: 5.315

Review 2.  Cardiovascular Imaging Techniques to Assess Microvascular Dysfunction.

Authors:  Roshin C Mathew; Jamieson M Bourque; Michael Salerno; Christopher M Kramer
Journal:  JACC Cardiovasc Imaging       Date:  2019-10-11

Review 3.  Coronary Computed Tomography Angiography: Enhancing Risk Stratification and Diagnosis of Cardiovascular Disease in Women.

Authors:  Sara Karnib; Kavitha M Chinnaiyan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-10-04

4.  Computed tomographic myocardial mass compared with invasive myocardial perfusion measurement.

Authors:  Daniëlle C J Keulards; Stephane Fournier; Marcel van 't Veer; Iginio Colaiori; Jo M Zelis; Mohamed El Farissi; Frederik M Zimmermann; Carlos Collet; Bernard De Bruyne; Nico H J Pijls
Journal:  Heart       Date:  2020-05-29       Impact factor: 5.994

Review 5.  Coronary Microvascular Disease.

Authors:  Ravi A Thakker; Jorge Rodriguez Lozano; Patricia Rodriguez Lozano; Afaq Motiwala; Umamahesh Rangasetty; Wissam Khalife; Khaled Chatila
Journal:  Cardiol Ther       Date:  2022-01-07

6.  Impaired Coronary Blood Flow in Patients with Psoriasis: Findings from an Observational Cohort Study.

Authors:  Domingo E Uceda; Amit K Dey; Sundus S Lateef; Khaled Abdelrahman; Milena Aksentijevich; Aarthi S Reddy; Harry Choi; Justin A Rodante; Martin P Playford; David A Bluemke; Wunan Zhou; Marcus Y Chen; Joel M Gelfand; Nehal N Mehta
Journal:  J Invest Dermatol       Date:  2020-10-01       Impact factor: 8.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.